Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Purple, it doesn't take much to update it. All these little details they don't pay attention to don't look good in overall co's picture. Medify you can do better.
Medify's German web side wasn't updated from July 12.
I wonder why?
Very funny.
Now, Hu is in charge of Medyfy?
Agree with you on both of your posts.
Something is cooking but the fire is very low.
JONATHAN AND CO< COME ON!!!! PUT SOME WOOD IN THE FIRE!!!NOW!!!
There is no one to answer the call. Will try again later and post if anything.
Doc, did you buy any today or still waiting for 10c?
Clancy, if this is such a big deal for NHS and Medify is the one and only than why NHS is so quite? I'm not getting it.
So much for another exciting week.
Also send the following to Medify today w/o reply:
Please confirm present AS, OS , float and dividend being paid on Dec. 15.
Thank you,
Lem, it was my 1st e-mail to Jonathan today:
Hello Jonathan,
From your e-mail to me on Dec. 4:
Press packs being sent as we speak to:
BBC
Central (ITV)
Mirror
Mail
Reuters
BBC Radio
Express
Express and Star
Telegraph
Times
Guardian
Interviews already booked for tomorrow.
From your e-mail to me on Dec. 6:
The media are beginning to kick in. Some surprises for later this week.
No promised media coverage by now and no surprise.
Please explain.
Regards,
Clancy, this is my point exactly.
Today's Jonathan's response to me, and my response to him:
Jonathan:The news is starting to get out to the media. If you look at OnMedica and a few other sites you will pick us up.
Also tied up finishing off some preparation for Monday so taken my eye off the day to day stuff until that is concluded.
Me:Jonathan,
On Monday is Friday, on Friday is Monday ...
On last Monday you said " tomorrow".
Jonathan, with being such an event in UK by now Medify should be everywhere including Russian press.
You are nowhere and PPS is dropping. And unfortunately this is no surprise.
You done it before.
And than we could sell naked. I wonder if we could still buy naked? In fact I do both already. Thank you Medify.
Jonathan, no "surprise" is no surprise!
Doc,"If you could ONLY know ... lift-off" is "sure "?!
Doc, "For one thing, boost investor confidence."
This should be easy to do.
Heartlands uses RFID for patient identification
05 Dec 2006
The Heart of England NHS Foundation Trust has awarded Safe Surgery Systems Ltd a contract to supply a Radio Frequency Identification (RFID) patient identification system that links to electronic patient records on PDAs, allowing staff to identify patients before they go for surgery.
Hear of England will use wireless PDA’s and patient wristbands fitted with RFID technology to improve patient safety by mistake-proofing the clinical journey, and reducing the chance of patient identification errors in surgery.
The Safe Surgery System is a patient tracking and identification system which uses disposable RFID wristbands to ensure patients are correctly identified before they received surgery. The smart wristbands are linked to PDAs which clinician's use to call up electronic patient records that include a digital picture of the patient.
The system will be used to manage the pre-operative checks of patients, which immediately updates operating lists, thus improving theatre efficiency by avoiding delays.
Under a £300,000 contract Heart of England will initially introduce the RFID system into the ENT and Thoracic wards as part of its plans to use the technology to enhance patient safety and ensure the correct identification and tracking of patients. The hospital went out to OJEC procurement last March.
The Safe Surgery System will be rolled out in the two wards early next year and the company hope to see it implemented across the trust three to six months afterwards covering over half a million patients.
Safe Surgery Systems’ head of sales and marketing, Jeremy Turbervill, explained to E-Health Insider how the sytem works: “On admission each patient is photographed and given a single-use, RFID tagged wrist band. The digital photograph is saved to the electronic patient record which is available to all staff on the wards, operating theatres and recovery rooms to view and update the record and operating list.
“The surgeon, anaesthetist and preoperative nurses have Wireless PDAs with which they can view the same operating list and patient records, so when the patient moves from room to room the system recognises the patient from their RFID tag, and selects the appropriate patient record and photograph to ensure correct patient identification.”
A series of ‘traffic lights’ in the record will indicate which checks have been done and only when all the necessary checks are completed, and the ‘traffic lights’ are green, can the patient be moved to theatre.
Safe Surgery Systems claim the system can also save hospitals time and money, leading to an extra 1-2 cases per list can be performed due to the improvements. Turberville explained “The basic premise is to make sure that the staff have the right patients and offer them the right treatments and help, as well as the right preparation prior to the patient going to theatre. Patient safety is paramount and the Safe Surgery System can help reduce delays in the patient care system.”
Turbervill added: “The system helps to ensure less wasted time. It prompts staff when there are any delays in seeing patients and allows them to enter free text explaining why there was a delay, which is useful for audits later on.”
The smart wristband system was chosen following a successful pilot project at the Heartlands Hospital in one ward of the hospital’s ENT department, where Safe Surgery Systems were able to test and complete the RFID technology they are providing to the trust.
Research from the National Patient Safety Agency indicates that up to 10% of NHS inpatient episodes result in errors, of which about half are preventable. According to Safe Surgery Systems failures to carry out bedside checks, missing wristbands and staff not always asking patients their name before they receive blood all contribute to misidentification, and can result in the wrong treatment.
Safe Surgery Systems told EHI they hope to see other hospitals looking to invest in patient RFID tagging and are currently working with the DH, as part of their technologies in health external reference group to increase the visibility of RFID technologies.
Link
Safe Surgery Systems
© 2006 E-HEALTH-MEDIA LTD. ALL RIGHTS RESERVED.
"like adding $20,000 more for two million shares at a penny!"
Doc, I don't wish you good luck in being able to actually do it.
I just send my response on the last Jonathan's e-mail:
Jonathan,
AT NO TIME I COULD SELL AT PROFIT!
I'm in a very deep sh..t in this my investment and my only hope that all your hard work will pay off for us all in a very near future.
As always with my very best wishes to US ALL.
My POSITIVE take that something good may be is cooking with Medify now.
Doc, may be averaging with 20/25c buy now is not a bad idea.
GO MEDIFY GO!!!
As I stated before everything is tied up in Medify.
JONATHAN PLEASE START MOVING IT UP!!!
Me too.
Patients' notes accessible via new system Back to News
Dec 7 2006 5:15PM
A new mobile access application enabling patients' notes to be viewed has completed its developmental phase and is now available for field use.
MedifyRemote has been designed for use within the National Health Service (NHS) and uses a mobile secure link to provide remote access for home-visiting caregivers who need to view patients' details.
The company behind the product, Medify Solutions, said that the system, accessible via a Microsoft Pocket PC, does not require download time and removes the need for careworkers to store patient information on a laptop, which potentially carries a high risk.
Currently, MedifyRemote is the only system on the market which provides this remote access facility and was developed at NHS Doncaster Primary Care Trust.
Dr Martyn Coleman, senior lead GP on the project, underlined the potential benefits offered by the system.
"The advantages to all clinical staff will be enormous from this application and contribute greatly to improved patient care and staff morale," he said.
TUV Product Service, part of the TÜV SÜD Group of companies with 1bn Euros turnover, in excess of 9,500 employees and 500 locations worldwide, is a leading producer of Compliance and Assurance Solutions for the health sector. Please contact us (info@tuvps.co.uk) for further information.
© Adfero Ltd
Lem, the potential value of the company is much higher now than 2 years ago "Only our value is now worth 90% less."
And this is all that counts. Investors value, PPS and company's monetary real value is the name of the game.
Lem, than take a stronger one now. I WOULD APPRECIATE YOUR INPUT VERY MUCH.
My e-mail send yesterday:
Jonathan,
are you or Medify selling shares today?
Jonathan's response today:
No I am not selling nor is anyone associated with me or the company. I am as disappointed as you and believe me I have put more into the company than anyone and over the 12 years I would suggest more than everyone put together. So activity like this only annoys me and drives me forward to delivering.
You challenged me on actually delivering this time, well I would ask do you not think national approval is, orders form PCTs, partnerships with the biggest global corporations is delivering or would you just wish the company to be a typical pump and dump. I am here because this is a real business with an exceptional future, if quick profit is what you want then you should have got out earlier. But now that you’ve stayed, the bigger profit will be realised.!!!!!!!!!!!!
This I can only assume you mean profit. Well maybe, just maybe that is closer than you think.
Hi Doc, as you may know by now I respect you very much, and I can 2nd EVERYTHING you put in your response to Geetar. I was thinking about doing the same thing myself, but ended up only with a short sarcastic response. Thank you for taking your time and effort and for writing this very argumentative response. I too have tons of saved e-mails from Trevor and Jonathan to basically proof the same points you have been making. Also this being written by you, one of the strongest defenders and enthusiast of this company, speaks for itself.
Doc, please don't leave us!!! Take your medicine you have to take, stay with us, and be THE STAR on this board as you have been so far not only with your thoughts about this company, but your many timely advices you are giving about specific investments and investing in general.
Saying all of this I'm giving you a challenge.
I JUST GOT ANOTHER E-MAIL FROM JONATHAN ( how many times I was writing this one?). Please read this one w/o sarcasm and seriously. When Jonathan is answering my e-mails he counts that I'll post them right away for everyone.
So I challenge you Doc to write him an answer not just from you, but on behalf of all of us.
I'm asking each of you fellow medifyers to participate with your inputs.
Lets make it AN OFFICIAL RESPONCE FROM LONGTIME INVESTORS IN MEDIFY.
I will gladly submit it to Jonathan as our collective response.
And sorry Geetar I see nothing wrong in doing this. If you have been investing like I did based on promises from company's top people, buying at today's $18.60, 17+, 15+ prices based on how great company was doing or would be doing tomorrow back in March of 2005, and on 30c, 25, 20 based on the same 2 years later you are welcome to participate too.
Let company hear our collective voice, so they wouldn't have any doubt left about how we feel by now.
Let us hope that in making critical decisions for the company from now on they will NOT FORGET ABOUT US, THE LOYAL LONGTERM INVESTORS who supported and still supporting this company with our last money we put in this.
If Jonathan thinks that he deserves 33 mil shares, than we deserve much better than 1:12 reverse split.
Yes indeed VERY WELL DONE INTERVIEW by Ian.
Geetar, what a guy!!! Finally 1 good guy on the board!!!
Better days should be coming.
Geetar, so why no promised by JB and all ready to go interviews and PRs? And this is not the 1st time.
Still waiting on my last e-mail to JB:
Jonathan,
please be frank and honest. I put A LOT of my hard working money into this and I got R/S instead of free shares.
What is going on? WHY NO PROMISSED BY YOU NEWS?
Any hope for the GOOD surprise for a change?
When are you going to finally DELIVER on your good promises?
When you guys will stop selling?
Be A MANCH and please answer me, please!
Doc, JB may be selling his 31mil shares, so he will have only 2 mil out of 33 mil left, just as you wanted.
My Bid and Ask set on 0.
Just send one more e-mail to JB and no reply so far:
Me:
Jonathan,
are you or Medify selling shares today?
I think I would like yes to my last question. Agree on $7.
Me:
Is this all that you can tell me?
BBC, TV etc?
Are you intend to sell Medify in the near future?
JB:
Yes why ruin the surprise!
Hi Jonathan,
any UK media or partner's news today?
Regards,
Jonathan:
Google patient notes, PDA etc etc and open the article that refers to a patient notes. The media are beginning to kick in. Some surprises for later this week.
Items 2, 4 and 6 are the must. Than 9 around $10 is doable.
The company with diluted credibility has no truth in it.
PR SHOULD BE ISSUED BY PARTNERS OR UK MEDIA AS PROMISED by diluted company.